A new trading day began on Friday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price down -2.88% from the previous day of trading, before settling in for the closing price of $54.51. VKTX’s price has ranged from $11.55 to $99.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -6.20%. With a float of $108.05 million, this company’s outstanding shares have now reached $111.44 million.
Let’s look at the performance matrix of the company that is accounted for 27 employees. In terms of profitability, gross margin is 28.9%, operating margin of -30726.61%, and the pretax margin is -22741.06%.
Viking Therapeutics Inc (VKTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 3.04%, while institutional ownership is 73.81%. The most recent insider transaction that took place on Nov 08 ’24, was worth 137,333. In this transaction Director of this company sold 2,000 shares at a rate of $68.67, taking the stock ownership to the 47,965 shares. Before that another transaction happened on Nov 08 ’24, when Company’s Director proposed sale 2,000 for $68.67, making the entire transaction worth $137,333.
Viking Therapeutics Inc (VKTX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -6.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 36.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Viking Therapeutics Inc (NASDAQ: VKTX) saw its 5-day average volume 3.01 million, a negative change from its year-to-date volume of 4.51 million. As of the previous 9 days, the stock’s Stochastic %D was 73.69%. Additionally, its Average True Range was 3.98.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 16.36%, which indicates a significant decrease from 24.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.45% in the past 14 days, which was lower than the 88.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $62.73, while its 200-day Moving Average is $62.84. Nevertheless, the first resistance level for the watch stands at $54.05 in the near term. At $55.17, the stock is likely to face the second major resistance level. The third major resistance level sits at $55.79. If the price goes on to break the first support level at $52.31, it is likely to go to the next support level at $51.69. The third support level lies at $50.57 if the price breaches the second support level.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 5.73 billion, the company has a total of 111,436K Shares Outstanding. Currently, annual sales are 0 K while annual income is -85,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,940 K.
